MiR⁃484通过靶向MAPK8抑制人前体脂肪细胞的增殖与分化
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(81700707);江苏省妇幼健康科研项目面上项目(F201804)


MiR⁃484 inhibits human pre⁃adipocyte differentiation and proliferation by targeting MAPK8
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨miRNA-484在肥胖发生中的作用及其临床意义。方法:利用RT-qPCR 、CCK-8法、油红O染色及甘油三酯定量检测研究miR-484对人脂肪细胞增殖及成脂分化的作用。运用Targetscan7.2对miR-484的下游靶基因进行预测分析,并使用双荧光素酶实验验证miR-484与靶基因的结合,使用Western blot及RT-qPCR验证miR-484对靶基因的作用。结果:miR-484在人脂肪细胞分化成熟过程中逐渐低表达。过表达miR-484抑制人前体脂肪细胞的增殖及分化,而沉默miR-484与过表达作用相反。生物信息学预测发现MAPK8是miR-484的下游靶基因,且miR-484可抑制其mRNA及蛋白表达,同时过表达MAPK8可部分挽救miR-484对人前体脂肪细胞增殖分化的抑制。结论:miR-484可以通过抑制MAPK8的表达从而抑制人前体脂肪细胞的增殖与成脂分化。

    Abstract:

    Objective:This study aims to investigate the role of miR-484 in adipogenesis and its clinical potentiality. Methods:To explore the function of miR-484 in human pre-adipocyte(HPA)differentiation and proliferation,RT-qPCR,CCK-8,red oil staining and triglyceride content assays were conducted. Additionally,a dual-luciferase reporter assay demonstrated MAPK8,which predicted by Targetscan7.2,was a direct target gene of miR-484 during preadipocyte differentiation,and the results were confirmed by RT-qPCR and Western blot. Results:The miR-484 was down-regulated during HPA differentiation. The miR-484 inhibited the proliferation and differentiation in HPA,and silencing miR-484 had the opposite effects. A dual-luciferase reporter assay demonstrated MAPK8 was a direct target gene of miR-484. Additionally,over expression of MAPK8 could reserve the negative effect of miR-484 on differentiation and proliferation of pre-adipocytes. Conclusion:MiR-484 could inhibit HPA differentiation and proliferation by targeting MAPK8.

    参考文献
    相似文献
    引证文献
引用本文

仲逢钰,秦振英,李 婧,田 甜,牟雨虹,田慧琴,胡幼芳. MiR⁃484通过靶向MAPK8抑制人前体脂肪细胞的增殖与分化[J].南京医科大学学报(自然科学版),2022,42(3):325-332

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-07-26
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-03-28
  • 出版日期:
通知关闭
郑重声明